{"id":827175,"date":"2026-07-28T04:01:02","date_gmt":"2026-07-28T04:01:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=827175"},"modified":"2026-07-28T04:01:02","modified_gmt":"2026-07-28T04:01:02","slug":"calliope-health-expands-access-to-spravato-and-esketamine-treatment-for-bethesda-rockville-and-the-dc-metro-area","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/calliope-health-expands-access-to-spravato-and-esketamine-treatment-for-bethesda-rockville-and-the-dc-metro-area_827175.html","title":{"rendered":"Calliope Health Expands Access to Spravato and Esketamine Treatment for Bethesda, Rockville, and the DC Metro Area"},"content":{"rendered":"
\n
Calliope Health Ketamine <\/div>\n<\/div>\n
Calliope Health, a Bethesda, MD psychiatric clinic, is expanding access to Spravato (esketamine) and ketamine-assisted treatment for treatment-resistant depression, anxiety, and PTSD. As the FDA-approved option gains recognition nationally, the clinic broadens its reach across Bethesda, Rockville, Silver Spring, Washington, D.C., and Montgomery County, Maryland, with in-network insurance coverage through major providers.<\/div>\n

BETHESDA, MD – July 28, 2026 – <\/strong>Calliope Health, a psychiatric clinic based in Bethesda, Maryland, is expanding access to Spravato (esketamine) and ketamine-assisted treatment for depression, anxiety, and PTSD, serving patients throughout Bethesda, Rockville, Silver Spring, Washington, D.C., and the wider Montgomery County, Maryland region.<\/p>\n

A Treatment Option for a Widely Underserved Condition<\/strong><\/p>\n

Major depressive disorder affects an estimated 21 million adults in the U.S., and roughly one in three of those adults will not respond adequately to standard oral antidepressants alone, a condition clinically defined as treatment-resistant depression. Spravato (esketamine) nasal spray was first approved by the FDA in 2019 for treatment-resistant depression when used alongside an oral antidepressant, and in January 2025 the FDA approved it as a standalone monotherapy — the first treatment of its kind for adults who have not found relief through conventional antidepressants alone. Calliope Health offers Spravato<\/a> alongside IV ketamine infusions, giving patients more than one clinically supported path forward when standard treatment hasn’t worked.<\/p>\n

Serving Bethesda, Rockville, and the Wider DC Metro Region<\/strong><\/p>\n

Calliope Health treats patients from across the Washington, D.C. metro area, with a concentration of patients in Bethesda and Rockville, Maryland. The clinic also serves Silver Spring, Washington, D.C., and communities throughout Montgomery County, and is in-network for Spravato treatment and psychiatric medication management with Aetna, Cigna, CareFirst, and United (Optum) — coverage designed to make an otherwise costly treatment more accessible to patients who qualify.<\/p>\n

A Psychotherapist’s Personal Path to Founding Calliope Health<\/strong><\/p>\n

Calliope Health was founded in 2023 by Keith Miller, a Licensed Independent Clinical Social Worker who has practiced psychotherapy for two decades and has led Keith Miller Counseling, a separate Bethesda-based therapy practice, since 2007. Miller has said his own experience with ketamine treatment, after watching several of his therapy clients use it to make faster progress than they had with conventional approaches alone, shaped his decision to found a clinic built around it. That combination of clinical psychotherapy background and firsthand experience with the treatment has shaped Calliope Health’s approach, which pairs Spravato and ketamine infusions with structured psychotherapy support rather than offering medication on its own.<\/p>\n

Treatment Options and Insurance Coverage<\/strong><\/p>\n

The clinic offers Spravato Bethesda<\/a> (esketamine) nasal spray for treatment-resistant depression, IV ketamine infusions, and ketamine-assisted psychotherapy, treating anxiety, depression, and PTSD. Eligible Spravato patients can enroll in a program designed to reduce or eliminate their co-pay. Ketamine infusions and psychotherapy services are billed separately and are typically paid for out of pocket.<\/p>\n

“People searching for Spravato or esketamine are usually looking for something that’s already been proven to work when other treatments haven’t,” said Keith Miller, founder of Calliope Health.<\/em><\/p>\n

About Calliope Health<\/strong><\/p>\n

Calliope Health<\/a> is a psychotherapist-founded clinic in Bethesda, Maryland, offering insurance-covered Spravato, ketamine infusions, and psychotherapy for PTSD, depression, and anxiety. Founded in 2023, the clinic pairs FDA-approved and evidence-based treatments with structured psychological support for patients throughout Bethesda, Rockville, Silver Spring, Washington, D.C., and Montgomery County, Maryland. Learn more at calliope.health.<\/p>\n

Frequently Asked Questions<\/strong><\/p>\n

What is Spravato, and how is it different from ketamine infusions?<\/strong><\/p>\n

Spravato is the brand name for esketamine, an FDA-approved nasal spray used specifically for treatment-resistant depression and often covered by insurance. Ketamine infusions are administered intravenously and are typically paid for out of pocket. Calliope Health offers both and helps patients determine which option best fits their clinical needs.<\/p>\n

Is Spravato treatment covered by insurance?<\/strong><\/p>\n

Calliope Health is in-network for Spravato and psychiatric medication management with Aetna, Cigna, CareFirst, and United (Optum). The clinic verifies individual insurance benefits before treatment begins, and eligible patients can enroll in a program that reduces or eliminates their co-pay.<\/p>\n

How do I know if I qualify for <\/strong>Spravato treatment<\/a>?<\/strong><\/p>\n

Qualification typically starts with a consultation reviewing symptoms, treatment history, and goals. For insurance-covered Spravato, most plans require documentation that a patient has tried at least two antidepressant medications without sufficient relief.<\/p>\n

What conditions does Calliope Health treat?<\/strong><\/p>\n

The clinic treats depression, including treatment-resistant depression, anxiety, and PTSD, with treatment recommendations based on a comprehensive clinical evaluation.<\/p>\n

What does a typical treatment session involve?<\/strong><\/p>\n

IV ketamine sessions generally last about an hour, plus preparation and recovery time. Spravato visits run about two to two and a half hours and include a monitoring period afterward, as required by FDA guidelines. Patients remain awake throughout but may experience an altered, often introspective state; clinic staff are present to support the experience.<\/p>\n

Where is Calliope Health located, and what areas does it serve?<\/strong><\/p>\n

Calliope Health is based in Bethesda, Maryland, and serves patients throughout Rockville, Silver Spring, Washington, D.C., and communities across Montgomery County, Maryland.<\/p>\n

Is ketamine treatment safe?<\/strong><\/p>\n

When administered in a controlled medical setting by trained professionals, ketamine is considered safe and well tolerated for most patients; the World Health Organization includes it among essential medicines for health systems worldwide. Calliope Health conducts a full medical and psychiatric screening before treatment and monitors patients closely during each session.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Calliope Health Ketamine<\/a>
Contact Person:<\/strong> Support
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> (301) 828-9513
Address:<\/strong>4300 Montgomery Ave # 302
City:<\/strong> Bethesda
State:<\/strong> MD
Country:<\/strong> United States
Website:<\/strong> https:\/\/calliope.health\/<\/a><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Calliope Health Ketamine Calliope Health, a Bethesda, MD psychiatric clinic, is expanding access to Spravato (esketamine) and ketamine-assisted treatment for treatment-resistant depression, anxiety, and PTSD. As the FDA-approved option gains recognition nationally, the clinic broadens its reach across Bethesda, Rockville, … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[438,405,423],"tags":[],"class_list":["post-827175","post","type-post","status-publish","format-standard","hentry","category-Fitness","category-Health-Medicine","category-Professional-Services"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/827175","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=827175"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/827175\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=827175"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=827175"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=827175"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}